Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 9/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 5/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7541835 | 0.71 | MEN1 (0.40) | CNR1MEN1KMT2AEPHX1HTR7 | |
| SCHEMBL21833980 | 0.68 | MMP1 (0.36) | — | |
| SCHEMBL252402 | 0.66 | KIF11 (0.48) | TSHR | |
| SCHEMBL29972825 | 0.66 | KIF11 (0.48) | TSHR | |
| SCHEMBL4818310 | 0.66 | KIF11 (0.48) | TSHR | |
| SCHEMBL3240747 | 0.66 | MEN1 (0.53) | CNR1TSHRMEN1KMT2AEPHX2 | |
| Cyclobutanol SCHEMBL9815506 | 0.66 | CA2 (0.39) | TSHR | |
| SCHEMBL17306777 | 0.66 | RBP4 (0.54) | TSHRMEN1KMT2A | |
| Formaldehyde SCHEMBL28441436 | 0.65 | KIF11 (0.44) | TSHRMEN1KMT2A | |
| SCHEMBL3779052 | 0.64 | KIF11 (0.47) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200102271-A1 | ONIUM SALT, RESIST COMPOSITION, AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200102271-A1 | ONIUM SALT, RESIST COMPOSITION, AND PATTERN FORMING PROCESS | C1R, NHERF1, INSR | CNR1 66/4885TSHR 239/4885MEN1 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.